709031-39-0,
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride,
(1S,3S,5S)-2-AZABICYCLO[3.1.0]HEXANE-3-CARBOXAMIDE HCL,
JFUDIEFZSNQJBS-SHLRHQAISA-N,
SCHEMBL2469688,
DTXSID20468643,
ABP000767,
MFCD13151930,
AKOS016013244,
AC-26402,
AK128130,
AS-36479,
SC-86927,
AX8249921,
ST24033661,
Z1752,
X-3455,
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide, HCl,
(1s,3s,5s)-2-azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride salt,
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride/,
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide--hydrogen chloride (1/1),
Saxagliptin intermediate,
C6H11ClN2O,
ACN-031825,
CS-O-10731,
CID11564521,
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide,
(1S,3S,5S)-4-azabicyclo[3.1.0]hexane-3-carboxamide Hydrochloride,